AUSTIN, Texas, May 22, 2018 /PRNewswire/ -- Altogen Biosystems announced the launch of AltoFect, the second generation transfection reagent for primary cell types and hard-to-transfect cell lines.
LAS VEGAS, Nov. 3 Altogen Biosystems (www.altogen.com)announced launch of novel Nanoparticle-based transfection reagent for use inlaboratories and research facilities for animal testing. Transfection ...
AUSTIN, Texas, May 21, 2018 /PRNewswire/ -- Altogen Labs announced addition of five new in-house validated xenograft models (4T1, BxPC-3, Calu-6, MDA-MB-468, and PANC-1). This will make a total of 89 ...
About Altogen Biosystems Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of In Vivo and In Vitro transfection reagents for intracellular and ...
LAS VEGAS, May 31, 2018 /PRNewswire/ -- Altogen Biosystems is a manufacturer of life science research products that includes in vivo transfection reagents designed for tissue-targeted delivery of ...
Altogen Labs offers over 100 validated models of cell line-derived xenografts (CDX) and patient-derived xenografts (PDX), including syngeneic xenograft models. Xenograft IND testing services are ...
Altogen Biosystems announced launch of new contract research services. Located in Las Vegas, NV, Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, ...
AUSTIN, Texas--(BUSINESS WIRE)--Altogen Labs CRO, a preclinical contract research laboratory, announced its launch of microorganism ID bacteria identification service today. Microorganism ...
AUSTIN, Texas, March 16, 2022 /PRNewswire/ -- Altogen Labs is a GLP-compliant biotech laboratory that specializes in oncology research studies and provides preclinical testing of new medicines that ...
AUSTIN, Texas, Sept. 3, 2014 /PRNewswire/ -- Western Blot Service CRO, a biology contract research organization based in Austin, Texas, announced today that it is consolidating its years of expert ...
(MENAFN- Ameliorate Digital Consultancy) By 2029, the market for Bioremediation Technology is anticipated to be worth USD 28.92 billion, growing at a CAGR of 9.93%. An important factor in boosting the ...